JUPITER NEUROSCIENCES
Jupiter Neurosciences is a biotechnology company that focuses on developing a treatment for Alzheimer and rare neurological disorders.
JUPITER NEUROSCIENCES
Industry:
Biotechnology Pharmaceutical Product Research
Address:
Palm Beach Gardens, Florida, United States
Country:
United States
Website Url:
http://www.jupiterneurosciences.com
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Google Maps Amazon Oregon Region
Similar Organizations
STC Biologics
STC Biologics is a biotechnology company that offers biologics drug research and development services.
Current Employees Featured
Founder
Official Site Inspections
http://www.jupiterneurosciences.com
- Host name: ec2-54-184-103-125.us-west-2.compute.amazonaws.com
- IP address: 54.184.103.125
- Location: Boardman United States
- Latitude: 45.8491
- Longitude: -119.7143
- Metro Code: 810
- Timezone: America/Los_Angeles
- Postal: 97818
More informations about "Jupiter Neurosciences"
Home - Jupiter Neurosciences, Inc
The first of its kind . The anti-inflammatory, oxidative-stress-reducing, and other mechanisms of action enable Jupiter Neurosciences flagship product, JOTROL™, to have multiple potential …See details»
Corporate Fact Sheet - jupiterneurosciences.com
Organization dedicated to the pursuit of scientific research leading to treatments and a cure for Friedreich's ataxia. • numerousCatalent, Inc.: world's #1 drug development, delivery, and …See details»
Company - Jupiter Neurosciences, Inc
Leveraging extensive experience leading technology, marketing, and social media, designing and implementing systems, he is a valuable advisor for an organization looking to utilize …See details»
Jupiter Neurosciences, Inc. | LinkedIn
Jupiter Neurosciences, Inc. is a clinical-stage drug platform company focused on treating neuroinflammation. Our mission is to make a significant impact for patients and society through a safe and ...See details»
Jupiter Neurosciences - Crunchbase Company Profile & Funding
Jupiter Neurosciences is a biotechnology company that focuses on developing a treatment for Alzheimer and rare neurological disorders.See details»
Jupiter Neurosciences (JUNS) Company Profile & Description
1001 North US Highway 1, Suite 504 Jupiter, Florida 33477 United StatesSee details»
Jupiter Neurosciences, Inc. Expands its Executive Team
Sep 28, 2021 JUPITER, Fla., and BOSTON, Sept. 28, 2021 /PRNewswire/ -- Jupiter Neurosciences, Inc. ("Jupiter" or the "Company"), a clinical-stage pharmaceutical company advancing a pipeline focused on the ...See details»
Jupiter Orphan Therapeutics, Inc. Announces New …
JUPITER, Fla., Sept. 14, 2021 /PRNewswire/ -- Jupiter Orphan Therapeutics, Inc., a clinical stage pharmaceutical company focused on treating central nervous system (CNS) disorders and rare ...See details»
Jupiter Neurosciences, Inc. Announces New Corporate Offices
JUPITER, Fla. and BOSTON, Sept. 21, 2021 /PRNewswire/ — Jupiter Neurosciences, Inc. ("Jupiter" or the "Company"), a clinical-stage pharmaceutical company advancing a pipeline …See details»
Jupiter Neurosciences - Craft
Jupiter Neurosciences has 5 employees at their 1 location and $638.04 k in annual revenue in FY 2021. See insights on Jupiter Neurosciences including office locations, competitors, revenue, …See details»
Jupiter Neurosciences, Inc. Expands its Executive Team
JUPITER, Fla., and BOSTON, Sept. 28, 2021 /PRNewswire/ — Jupiter Neurosciences, Inc. ("Jupiter" or the "Company"), a clinical-stage pharmaceutical company advancing a pipeline …See details»
Jupiter Neurosciences - Company Profile - Tracxn
Jan 30, 2025 Developer of therapeutics for the treatment of neuroinflammation. The company has developed a unique resveratrol platform JOTROL which offers therapeutic benefits to …See details»
Jupiter Neurosciences Announces JOTROL Manufacturing
Feb 3, 2025 More information may be found on the Company’s website www.jupiterneurosciences.com. ... Catalent, Inc. is a leading global contract development and …See details»
Jupiter Neurosciences, Inc. Announces Closing of $11
Jupiter, Florida, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (Nasdaq: JUNS) (the “Company” or “Jupiter Neurosciences”), a clinical stage pharmaceutical company …See details»
Jupiter Orphan Therapeutics, Inc. Announces New Corporate
JUPITER, Fla., Sept. 14, 2021 /PRNewswire/ -- Jupiter Orphan Therapeutics, Inc., a clinical stage pharmaceutical company focused on treating central nervous system (CNS) disorders and …See details»
Jupiter Neurosciences, Inc. - Drug pipelines, Patents ... - Patsnap
More information may be found on the Company’s website www.jupiterneurosciences.com. FORWARD-LOOKING STATEMENTS Certain statements in this announcement are forward …See details»
Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial ...
Jupiter, Florida, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (Nasdaq: JUNS) (the “Company” or “Jupiter Neurosciences”), a clinical stage pharmaceutical company …See details»
Jupiter Neurosciences Announces Strategic Focus on NLRP3 …
Jupiter, Florida, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing …See details»
Jupiter Neurosciences, Inc. Announces Broadening of IP Estate for …
Mar 1, 2022 JUPITER, Fla. and BOSTON, March 1, 2022 /PRNewswire/ — Jupiter Neurosciences, Inc. ("Jupiter" or the "Company"), today announced the issuance of additional …See details»
Jupiter Neurosciences Highlights Upcoming Milestones in …
Apr 8, 2025 Strategic expansion into longevity market creates near-term commercial opportunity alongside continued clinical advancement of JOTROL™ JOTROL™ development programs …See details»